Insulin-Glucose-Glucagon Network: Defining a Type 1 Diabetes Progression Index

NACompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

March 16, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Diabetes Mellitus, Type 1
Interventions
PROCEDURE

Metabolic Challenge Admission

A ten hour clinical test involving drinking a liquid mixed meal followed four hours later by the induction of hypoglycemia with intravenous insulin administration.

OTHER

CGM home test

A home study starting immediately after the clinical test during which participants will wear a continuous glucose monitor (CGM) for one week.

Trial Locations (1)

22903

University of Virginia, Center for Diabetes Technology, Charlottesville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Virginia

OTHER

NCT02663661 - Insulin-Glucose-Glucagon Network: Defining a Type 1 Diabetes Progression Index | Biotech Hunter | Biotech Hunter